Cardiovascular Systems Current Ratio 2006-2019 | CSII

Cardiovascular Systems current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Cardiovascular Systems Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.18B $0.04B 4.25
2019-03-31 $0.17B $0.04B 4.25
2018-12-31 $0.17B $0.04B 4.38
2018-09-30 $0.17B $0.04B 4.54
2018-06-30 $0.17B $0.04B 4.47
2018-03-31 $0.16B $0.04B 4.46
2017-12-31 $0.16B $0.03B 4.65
2017-09-30 $0.16B $0.04B 4.30
2017-06-30 $0.16B $0.04B 3.88
2017-03-31 $0.15B $0.04B 3.93
2016-12-31 $0.12B $0.03B 3.80
2016-09-30 $0.10B $0.03B 3.35
2016-06-30 $0.11B $0.04B 2.96
2016-03-31 $0.11B $0.04B 3.05
2015-12-31 $0.11B $0.03B 4.03
2015-09-30 $0.12B $0.03B 4.13
2015-06-30 $0.13B $0.03B 4.48
2015-03-31 $0.14B $0.03B 4.19
2014-12-31 $0.15B $0.03B 4.77
2014-09-30 $0.16B $0.03B 4.91
2014-06-30 $0.16B $0.03B 5.47
2014-03-31 $0.18B $0.03B 6.14
2013-12-31 $0.17B $0.03B 7.03
2013-09-30 $0.09B $0.02B 3.67
2013-06-30 $0.09B $0.02B 4.01
2013-03-31 $0.09B $0.02B 4.65
2012-12-31 $0.05B $0.02B 2.98
2012-09-30 $0.05B $0.02B 2.79
2012-06-30 $0.06B $0.02B 3.24
2012-03-31 $0.04B $0.02B 2.74
2011-12-31 $0.05B $0.01B 3.25
2011-09-30 $0.04B $0.02B 2.83
2011-06-30 $0.04B $0.02B 2.70
2011-03-31 $0.04B $0.02B 2.43
2010-12-31 $0.04B $0.02B 2.54
2010-09-30 $0.04B $0.02B 2.13
2010-06-30 $0.04B $0.01B 2.87
2010-03-31 $0.06B $0.03B 1.82
2009-12-31 $0.06B $0.03B 1.74
2009-09-30 $0.07B $0.04B 1.86
2009-06-30 $0.05B $0.04B 1.27
2009-03-31 $0.05B $0.03B 1.46
2008-12-31 $0.00B 0.00
2008-09-30 $0.05B $0.01B 7.55
2008-06-30 $0.00B 0.00
2008-03-31 $0.08B $0.01B 9.83
2007-12-31 $0.00B 0.00
2007-09-30 $0.11B $0.01B 12.59
2007-06-30 $0.11B $0.01B 17.17
2007-03-31 $0.12B $0.06B 1.97
2006-12-31 $0.00B 0.00
2006-09-30 $0.14B $0.01B 14.48
2006-06-30 $0.10B $0.01B 8.80
2006-03-31 $0.00B 0.00
2005-12-31 $0.06B $0.01B 6.45
2005-09-30 $0.00B 0.00
2005-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.770B $0.248B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.052B 28.21
Medtronic (MDT) Ireland $144.563B 20.30
Stryker (SYK) United States $81.936B 28.33
Boston Scientific (BSX) United States $59.271B 28.75
Baxter (BAX) United States $44.577B 27.03
EssilorLuxottica Societe Anonyme (ESLOY) France $31.834B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.216B 18.06
Coloplast (CLPBY) Denmark $27.065B 43.21
Lonza Group Ag (LZAGY) Switzerland $26.916B 0.00
Terumo (TRUMY) Japan $23.348B 26.85
Smith & Nephew SNATS (SNN) United Kingdom $20.643B 0.00
ResMed (RMD) United States $19.620B 37.41
Sunny Optical Technology (SNPTF) China $14.851B 0.00
Bio-Rad Laboratories (BIO) United States $10.257B 54.98
Insulet (PODD) United States $9.281B 549.93
Canopy Growth (CGC) Canada $9.211B 0.00
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.050B 21.02
Haemonetics (HAE) United States $6.871B 51.85
Perrigo (PRGO) Ireland $6.520B 12.01
GN STORE NORD (GNNDY) Denmark $6.268B 32.01
Aurora Cannabis (ACB) Canada $5.942B 58.40
GW Pharmaceuticals (GWPH) United Kingdom $4.611B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.773B 62.76
NuVasive (NUVA) United States $3.412B 27.20
ICU Medical (ICUI) United States $3.409B 22.11
Hutchison China MediTech (HCM) China $2.720B 0.00
Agios Pharmaceuticals (AGIO) United States $2.553B 0.00
Quidel (QDEL) United States $2.549B 25.31
National Vision Holdings (EYE) United States $2.221B 47.93
Aphria (APHA) $1.652B 0.00
Phibro Animal Health (PAHC) United States $1.292B 19.36
AtriCure (ATRC) United States $1.054B 0.00
VAREX IMAGING (VREX) United States $1.047B 24.12
Omeros (OMER) United States $1.003B 0.00
NanoString Technologies (NSTG) United States $0.957B 0.00
PetIQ (PETQ) United States $0.902B 21.30
Lantheus Holdings (LNTH) United States $0.900B 23.65
Eagle Pharmaceuticals (EGRX) United States $0.806B 20.56
Cerus (CERS) United States $0.773B 0.00
MacroGenics (MGNX) United States $0.751B 0.00
Quanterix (QTRX) United States $0.687B 0.00
TG Therapeutics (TGTX) United States $0.641B 0.00
LeMaitre Vascular (LMAT) United States $0.629B 37.27
Surmodics (SRDX) United States $0.604B 114.72
OraSure Technologies (OSUR) United States $0.453B 20.97
United Health Products (UEEC) United States $0.433B 0.00
Meridian Bioscience (VIVO) United States $0.419B 13.09
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.399B 0.00
BioLife Solutions (BLFS) United States $0.395B 129.88
Utah Medical Products (UTMD) United States $0.346B 25.35
Zynex (ZYXI) United States $0.336B 35.65
Owens & Minor (OMI) United States $0.296B 8.87
Bovie Medical (APYX) United States $0.265B 0.00
Vapotherm (VAPO) United States $0.229B 0.00
Cytosorbents (CTSO) United States $0.156B 0.00
Rockwell Medical (RMTI) United States $0.154B 0.00
Fonar (FONR) United States $0.154B 8.11
Chimerix (CMRX) United States $0.148B 0.00
Female Health (VERU) United States $0.131B 0.00
InfuSystems Holdings (INFU) United States $0.098B 0.00
United-Guardian (UG) United States $0.090B 21.22
Chembio Diagnostics (CEMI) United States $0.089B 0.00
Surface Oncology (SURF) United States $0.059B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Nephros (NEPH) United States $0.053B 0.00
MRI INTERVENTNS (MRIC) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.035B 0.00
Myomo (MYO) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00